# ADNI (Alzheimer's Disease Neuroimaging Initiative)
> The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite longitudinal study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer's disease. Launched in 2004, it operates as a public-private partnership, providing open-access data to researchers worldwide to accelerate the development of new treatments.
- URL: https://optimly.ai/brand/adni-alzheimer-s-disease-neuroimaging-initiative
- Slug: adni-alzheimer-s-disease-neuroimaging-initiative
- BAI Score: 88/100
- Archetype: Challenger
- Category: Research Initiative
- Last Analyzed: April 9, 2026
## Buyer Intent Signals
Problems: Manual Literature Review & Meta-Analysis: Researchers manually collate data from individual clinical trials or published literature without a centralized ecosystem. | Siloed Institutional Research: Conducting independent, isolated clinical longitudinal studies at a single institution.
Solutions: Alzheimer's disease longitudinal study data access | ADNI-4 recruitment goals | Public-private partnership for Alzheimer's research | Standardized biomarkers for AD progression | how to volunteer for brain imaging studies near me | UK Biobank: The UK Biobank provides large-scale genetic and health data, though not exclusively focused on AD progression markers like ADNI.
---
## Full Details / RAG Data
### Overview
ADNI (Alzheimer's Disease Neuroimaging Initiative) is listed in the AI Directory.
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite longitudinal study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer's disease. Launched in 2004, it operates as a public-private partnership, providing open-access data to researchers worldwide to accelerate the development of new treatments.
### Metadata
| Field        | Value |
|--------------|-------|
| Name         | ADNI (Alzheimer's Disease Neuroimaging Initiative) |
| Slug         | adni-alzheimer-s-disease-neuroimaging-initiative |
| URL          | https://optimly.ai/brand/adni-alzheimer-s-disease-neuroimaging-initiative |
| BAI Score    | 88/100 |
| Archetype    | Challenger |
| Category     | Research Initiative |
| Last Analyzed | April 9, 2026 |
| Last Updated | 2026-04-25T12:18:56.844Z |
### Verified Facts
- Founded: 2004
- Headquarters: San Francisco, CA (Lead site at UCSF)
### Buyer Intent Signals
#### Problems this brand solves
- Manual Literature Review & Meta-Analysis: Researchers manually collate data from individual clinical trials or published literature without a centralized ecosystem.
- Siloed Institutional Research: Conducting independent, isolated clinical longitudinal studies at a single institution.
#### Buyers search for
- Alzheimer's disease longitudinal study data access
- ADNI-4 recruitment goals
- Public-private partnership for Alzheimer's research
- Standardized biomarkers for AD progression
- how to volunteer for brain imaging studies near me
- UK Biobank: The UK Biobank provides large-scale genetic and health data, though not exclusively focused on AD progression markers like ADNI.
### Links
- Canonical page: https://optimly.ai/brand/adni-alzheimer-s-disease-neuroimaging-initiative
- JSON endpoint: /brand/adni-alzheimer-s-disease-neuroimaging-initiative.json
- LLMs.txt: /brand/adni-alzheimer-s-disease-neuroimaging-initiative/llms.txt